Descriptor English: Meglumine Antimoniate
Descriptor Spanish: Antimoniato de Meglumina
Descriptor Portuguese: Antimoniato de Meglumina
Descriptor French: Antimoniate de méglumine
Entry term(s): Glucantime
N Methylglucamine Antimonate
N-Methylglucamine Antimonate
Tree number(s): D02.033.800.813.550.800
RDF Unique Identifier:
Scope note: ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antiprotozoal Agents
Registry Number: 75G4TW236W
CAS Type 1 Name: 1-Deoxy-1-(methylamino)glucitol antimonate(V)
Public MeSH Note: 2019; MEGLUMINE ANTIMONATE was indexed under MEGLUMINE and ORGANOMETALLIC COMPOUNDS 1978-2018; under AMINO SUGARS 1974-1977; under SORBITOL/analogs 1975-1977; and under SORBITOL 1972-1975
History Note: 2019 (1972)
DeCS ID: 57658
Unique ID: D000077485
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/04/09
Meglumine Antimoniate - Preferred
Concept UI M0428130
Scope note ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS.
Preferred term Meglumine Antimoniate
Glucantime - Narrower
Concept UI M0046715
Preferred term Glucantime
N-Methylglucamine Antimonate - Narrower
Concept UI M000640802
Preferred term N-Methylglucamine Antimonate
Entry term(s) N Methylglucamine Antimonate

We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey